Farris Marietta K, Petty Michael, Hamilton Jennifer, Walters Shelley-Ann, Flynn Michael A
Marietta K. Farris, MAN, RN, Patient Care Unit 7B, Minneapolis, Minnesota. Michael Petty, PhD, RN, CCNS, ACNS-BC, University of Minnesota Medical Center, Fairview. Jennifer H. Hamilton, BA, 3M, Minneapolis, Minnesota. Shelley-Ann Walters, MS, 3M, Minneapolis, Minnesota. Michael A. Flynn, MPH, RN, Medica, Minneapolis, Minnesota.
J Wound Ostomy Continence Nurs. 2015 Nov-Dec;42(6):589-98. doi: 10.1097/WON.0000000000000179.
The purpose of this study was to measure the daily prevalence of adhesive product use and related skin injuries in adult patients in a non-intensive care unit setting.
Prospective, descriptive study.
The study sample consisted of patients cared for on 2 inpatient care units in a university-based acute care facility in the Midwestern United States. One was a 30-bed medical/surgical unit and the second was a 35-bed cardiac/telemetry unit. Their median age was 58 years; the average daily proportion of males and females was 56% and 42%, respectively.
Medical adhesive-related skin injury (MARSI) prevalence was calculated using 3 methods: (1) the proportion of subjects who had any MARSI injury (subject prevalence), (2) the prevalence of MARSI by injury type and severity (severity prevalence), and (3) the proportion of medical adhesive products that had any associated MARSI (product prevalence).
The daily subject prevalence of any MARSI injury ranged from 3.4% to 25.0% with a mean and median of 13.0% and 12.7%, respectively. The severity prevalence of MARSI injury ranged from 8 to 149 per 1000 product-days with a mean and median of 63 and 56 MARSIs per 1000 product-days, respectively. The median (range) product prevalence among all adhesive products varied from a high of 70 injuries per 1000 product-days for surgical closure to a low of 0 injuries per 1000 product-days for peripheral intravenous line dressing.
Medical adhesive-related skin injury is a prevalent event in the acute care setting. Preventing skin injury has the potential to reduce complications, increase patient satisfaction, and improve clinical outcomes.
本研究旨在测量非重症监护病房环境下成年患者使用粘性产品及相关皮肤损伤的每日发生率。
前瞻性描述性研究。
研究样本包括在美国中西部一家大学附属医院的两个住院护理单元接受治疗的患者。一个是拥有30张床位的内科/外科病房，另一个是拥有35张床位的心脏/遥测病房。患者的中位年龄为58岁；男性和女性的日均比例分别为56%和42%。
使用三种方法计算与医用胶粘剂相关的皮肤损伤（MARSI）发生率：（1）发生任何MARSI损伤的受试者比例（受试者发生率），（2）按损伤类型和严重程度计算的MARSI发生率（严重程度发生率），以及（3）发生任何相关MARSI的医用胶粘剂产品比例（产品发生率）。
任何MARSI损伤的每日受试者发生率在3.4%至25.0%之间，均值和中位数分别为13.0%和12.7%。MARSI损伤的严重程度发生率为每1000产品日8至149例，均值和中位数分别为每1000产品日63例和56例。所有粘性产品的产品发生率中位数（范围）各不相同，手术缝合产品的发生率最高，为每1000产品日70例损伤，外周静脉输液敷料的发生率最低，为每1000产品日0例损伤。
在急性护理环境中，与医用胶粘剂相关的皮肤损伤是一种常见事件。预防皮肤损伤有可能减少并发症、提高患者满意度并改善临床结果。
